Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2025. Start Trial.
Date Value
September 30, 2026 4.283M
June 30, 2026 6.091M
March 31, 2026 30.52M
Date Value
December 31, 2025 291.61M
September 30, 2025 -1.679M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Biodesix, Inc. 6.216M
Quest Diagnostics, Inc. -271.00M
Labcorp Holdings, Inc. -10.00M
OPKO Health, Inc. 114.47M
Psychemedics Corp. --